Publications

Export 6 results:
Auteur [ Title(Desc)] Type Année
Filtres: Auteur is Giacobbe, Peter  [Enlever les filtres]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Baskaran A, Farzan F, Milev R, Brenner CA, Alturi S, McAndrews MPat, Blier P, Evans K, Foster JA, Frey BN et al..  2017.  The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study.. J Affect Disord. 227:542-549.
D
Leoutsakos J-MS, Yan H, Anderson WS, Asaad WF, Baltuch G, Burke A, M Chakravarty M, Drake KE, Foote KD, Fosdick L et al..  2018.  Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation.. J Alzheimers Dis. 64(2):597-606.
Lam RW, Milev R, Rotzinger S, Andreazza AC, Blier P, Brenner C, Daskalakis ZJ, Dharsee M, Downar J, Evans KR et al..  2016.  Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.. BMC Psychiatry. 16:105.
E
Berlim M, McGirr A, Van den Eynde F, Fleck MPA, Giacobbe P.  2014.  Effectiveness and acceptability of deep brain stimulation (DBS) of the subgenual cingulate cortex for treatment-resistant depression: a systematic review and exploratory meta-analysis.. J Affect Disord. 159:31-8.
M
Lopez JPablo, Fiori LM, Cruceanu C, Lin R, Labonte B, Cates HM, Heller EA, Vialou V, Ku SM, Gerald C et al..  2017.  MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes.. Nat Commun. 8:15497.
P
Lozano AM, Fosdick L, M Chakravarty M, Leoutsakos J-M, Munro C, Oh E, Drake KE, Lyman CH, Rosenberg PB, Anderson WS et al..  2016.  A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease.. J Alzheimers Dis. 54(2):777-87.

McGill Logo

CIUSSS ouest montreal logo

 

  • Douglas Hospital
  • Dobell Pavillion
  • Brain imaging centre